IINN - Inspira Technologies Oxy PEG Multiple
Inspira Technologies Oxy develops blood oxygen molecular saturation systems, ensuring high margins through its patents. An R&D breakthrough in ART devices is transforming resuscitation standards. The PEG fundamental indicator captures this trend, with the value holding at 0.00, confirming the potential for undervaluation. Compact oxygenation solutions also contribute to achieving ESG goals in medicine.
Inspira Technologies Oxy B.H.N. Ltd. (IINN) - metric breakdowns and financial figures
- current quotes and average value forecast:
- market capitalization statistics:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Equity Ratio Inspira Technologies Oxy|IINN - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Inspira Technologies Oxy B.H.N. Ltd.|IINN - Company Debts|Debt to Book Value Inspira Technologies|IINN - Company Long-Term Debts|Short-Term Debt Inspira Technologies|Immediate Liquidity Ratio inspira-technologies.com
- earnings and market ratios statistics:
IINN - Net Profit|Company Profit Forecast Inspira Technologies Oxy|IINN - P/E Multiple|Projected Price to Earnings Inspira Technologies|IINN - PEG Multiple|EV/EBITDA Multiple Inspira Technologies|IINN - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Inspira Technologies|IINN - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months inspira-technologies.com|IINN - Earnings growth in current year|Expected net earnings per share growth next year Inspira Technologies Oxy
- issuer revenue and sales details:
Fundamental company analysis:IINN (Inspira Technologies Oxy B.H.N. Ltd)
The uniqueness of Inspira Technologies Oxy respiratory support systems creates a steady stream of service revenue through the sale of consumables. The P/E ratio relative to earnings growth rates allows for an assessment of the cost of this growth. This coefficient determines the fairness of the market premium for future business expansion. GURU.Markets analysts utilize the PEG undervaluation factor to identify hidden potential, where values below one signal that the asset is undervalued.
Competing companies
DXCM - Price to Earnings Adjusted for Growth Rate|Penumbra Corp - Price/Earnings to Growth Multiple|PEG Multiple Novanta NOVT|Haemonetics Corp - PEG Multiple|Inspire Medical Systems, Inc. - Company Value to Earnings Growth Ratio|PRCT: PEG Multiple|CNMD - Growth-Adjusted Market Cap to Net Income|PLSE (pulsebiosciences.com) - PEG Multiple|Price/Earnings to Growth Multiple InMode (INMD)|Price/Earnings to Growth Ratio Picard Medical Corp (PMI)|SRDX (Surmodics Inc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Senseonics Holdings SENS|NPCE - Price/Earnings to Growth Multiple|Tactile Systems Technology Inc. - PEG Multiple|Price to Earnings Adjusted for Growth Rate Sanuwave Health Inc|OM: PEG Multiple|Growth-Adjusted P/E Ratio ELMD|LNSR (LENSAR Inc) - PEG Multiple|AVITA Medical, Inc (RCEL) - Growth-Adjusted Market Cap to Net Income|PEG Multiple PROF|Price/Earnings to Growth Multiple Baird Medical BDMD|PEG Multiple EDAP (EDAP TMS SA)|PEG Multiple Apyx Medical APYX|ICCM - Price/Earnings to Growth Ratio|LUNG: Price/Earnings to Growth Ratio|TELA (TELA Bio Corp) - Price/Earnings to Growth Multiple|CytoSorbents Corp - Growth-Adjusted Payback Ratio|SRTS (Sensus) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Zynex Medical ZYXI|Price/Earnings to Growth Ratio electroCore (ECOR)|Vicarious Surgical Corp (RBOT) - Price to Net Income Growth Ratio|PEG Multiple ICU (seastarmedical.com)|PEG Multiple IRIDEX Corp. IRIX|Intelligent Bio Solutions Inc - PEG Multiple|Growth-Adjusted Market Cap to Net Income Beyond Air XAIR|Profusa (PFSA) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio SSKN (STRATA Skin)|Price/Earnings to Growth Ratio glucotrack.com|Price/Earnings to Growth Multiple NanoVibronix, Inc. (NAOV)|PEG Multiple VERO|NUWE - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Aethlon Medical AEMD|ASXC: Growth-Adjusted P/E Ratio|AVGR: Price/Earnings to Growth Multiple|BioSig Technologies, Inc. - Company Value to Earnings Growth Ratio|CUTR: PEG Multiple|Growth-Adjusted P/E Ratio KNW|Price/Earnings to Growth Ratio Inari Medical, Inc.|Price to Earnings Adjusted for Growth Rate Nevro Corp. NVRO|Price/Earnings to Growth Ratio ReShape Lifesciences Inc (RSLS)|Price/Earnings to Growth Ratio SILK (silkroadmed.com)
